The effect of enoxaparin on sudden sensorineural deafness

Phase 2

Recruiting

• Conditions: Sudden sensorineural hearing loss.; Sensorineural hearing loss, bilateral; H90.3

• Registration Number: IRCT20211010052721N2
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 August 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Conscious consent to participate in the study
Patients with sudden sensorineural hearing loss that progresses rapidly and no known cause is found for more than 72 hours

Exclusion Criteria

History of ear diseases
Patients with contraindications to treatment with systemic corticosteroids or anticoagulants such as diabetes mellitus
History of intermittent hearing loss
Pregnancy
Breastfeeding

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Average hearing threshold. Timepoint: Before the intervention and 10 days after starting taking enoxaparin. Method of measurement: Audiometry.